Bolt Biotherapeutics, Inc. (BOLT) — 分析师展望 / 分析师共识目标价为. 基于 8 位分析师评级, 共识为 看涨 — 3 买入, 5 持有.
分析师共识目标价为 $7.00, 上涨空间为 50.2% 相对于当前价格 $4.66.
分析师预估 每股收益(EPS)为 $-32.27 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.65 vs 预期 $-32.27 (超预期 +94.9%). 2025: 实际 $-17.85 vs 预期 $-21.23 (超预期 +15.9%). 分析师准确度: 0%.
BOLT 股票 — 12个月价格预测
$7.00
▲ +50.21% 上涨空间
平均目标价
Based on 8 Wall Street analysts offering 12-month price targets for Bolt Biotherapeutics, Inc., the price target is $7.00.
平均目标价相对最新价格 $4.66 变动 +50.21%。
BOLT 分析师评级
Hold
基于过去3个月内 8 位分析师对 Bolt Biotherapeutics, Inc. 的评级
EPS 预测 — BOLT
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.65
vs Est –$32.27
▲ 1,855.6% off
2025
Actual –$17.85
vs Est –$21.23
▲ 18.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — BOLT
83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.008B
vs Est $0.008B
▼ 10.2% off
2025
Actual $0.008B
vs Est $0.006B
▲ 23.8% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
